World Journal of
Pharmaceutical and Life Sciences

ARTIFICIAL INTELLIGENCE IN PANCREATIC CANCER THERAPY

Shubamalya L. G.*, Dr. B. V. Krishna Reddy and Dr. V. Guna Sekharan

ABSTRACT

In the field of oncology, pancreatic cancer poses a significant problem due to its aggressive nature and poor
prognosis. The overall survival rates for pancreatic cancer are still poor, despite advancements in treatment
modalities, which highlights the critical need for novel strategies to enhance patient outcomes. Artificial
intelligence (AI) has been a promising new area of pancreatic cancer therapy in recent years, with the potential to
revolutionize patient care at all stages. AI has the potential to completely transform the management of pancreatic
cancer by utilizing cutting-edge computational algorithms and machine learning techniques. These techniques
could be applied to early detection, personalized treatment planning, predictive analytics, drug discovery, radiation
therapy optimization, clinical decision support, and patient engagement. In order to provide the groundwork for a
thorough investigation of AI's potential applications and implications for enhancing the prognosis and quality of
life for pancreatic cancer patients, this paper offers an overview of the rapidly developing field of the technology.

[Full Text Article]   [Download Certificate]